期刊文献+

色素上皮衍生因子抑制高糖诱导的人肾小球系膜细胞转化生长因子β1、纤连蛋白和Ⅳ型胶原的表达 被引量:3

Pigment epithelium-derived factor inhibits high glucose-stimulated transforming growth factor β1,fibronectin, and collagen Ⅳ expressions in human mesangial cells
原文传递
导出
摘要 随着葡萄糖浓度的增加,人肾小球系膜细胞转化生长因子β1(TGF-β1)、纤连蛋白(FN)和Ⅳ型胶原(ColⅣ)的表达显著增加(P<0.01).在30 mmol/L的高糖条件下,40~160 nmol/L的色素上皮衍生因子(PEDF)显著抑制TGF-β1表达,呈剂量依赖性(P<0.01);5~40 nmol/L的PEDF也剂量依赖性地抑制FN和ColⅣ的表达(P<0.01),提示PEDF可能通过其抗纤维化的作用延缓糖尿病肾病的进程. The expressions of transforming growth factor β1 (TGF-β1), fibronectin (FN), and collagen Ⅳ in human mesangial cells were augmented with increased concentrations of glucose.Pigment epithelium-derived factor (PEDF) at concentrations of 40-160 nmol/L significantly inhibited TGF-β1 expression in a dose-dependent manner(P〈0.01).PEDF at concentrations of 5-40 nmol/L significantly decreased FN and collagen Ⅳ expressions in a dose-dependent manner(P〈0.01) ,suggesting that PEDF may play a salutary role in diabetic nephropathy by its antifibrogenic activity.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2011年第1期70-71,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 色素上皮衍生因子 转化生长因子Β1 纤连蛋白 Ⅳ型胶原 Pigment epithelium-derived factor Transforming growth factor β1 Fibronectin Collagen Ⅳ
  • 相关文献

参考文献8

  • 1Ziyadeh FN,Sharma K.Overview:combating diabetic nephropathy.Am J Soc Nephrol,2003,14:1355-1357.
  • 2Wang JJ,Zhang SX,Lu K,et al.Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy.Diabetes,2005,54:243-250.
  • 3Liu H,Ren JG,Cooper WL.,et al.Identification of the antivasopermeability effect of pigment epithelium derived factor and its active site.Proc Nall Acad Sci USA,2004,101:6605-6610.
  • 4李竞,李珍瑾,崔静,王蜀鄂,包艳,叶迎春.VEGF和色素上皮衍生因子的表达失衡对糖尿病肾病的影响[J].中华内分泌代谢杂志,2009,25(2):203-205. 被引量:14
  • 5Wang JJ,Zhang SX,Mott R,et al.Salutary effect of pigment epithelium-derived factor in diabetic nephropathy:evidence for antifibrogenic activities.Diabetes,2006,55:1678-1685.
  • 6Pantsulaia T.Role of TGF-beta in pathogenesis of diabetic nephropathy.Georgian Med News,2006,131:13-18.
  • 7Brosius FC 3rd.New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy.Rev Endocr Metab Disord,2008,9:245-254.
  • 8Mason RM,Wahab NA.Extracellular matrix metabolism in diabetic nephropathy.J Am Soc Nephrol,2003,14:1358-1373.

二级参考文献6

  • 1Ziyadeh FN, Sharma K. Overview : combating diabetic nephropathy. Am J Soc Nephrol, 2003,14 : 1355-1357.
  • 2Wang JJ, Zhang SX, Lu K, et al. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy. Diabetes, 2005,54:243-250.
  • 3Choi Y, Chakraborty S, Nguyen V, et al. Peritublar capillary loss isassociated with chronic tubulointerstilial injury in human kidney: altered expression of vascular endothelial growth factor. Human Pathol, 2000, 31:1491-1497.
  • 4Wang JJ, Zhartg SX, Mott R, et al. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy : evidence for antifibrogenic activities. Diabetes, 2006,55 : 1678-1685.
  • 5Abramson LP, Stellmach V, Doll JA, et al. Wilms'tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. J Pediatr Surg, 2003,38:336-342.
  • 6Zhang SX, Wang .l J, Gao G, et al. Pigment epithelium-derived factor , downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol, 2006,37 : 1-12.

共引文献13

同被引文献22

  • 1Banumathi E, Sheikpranbabu S, Haribalaganesh R, et al. PEDF pre- vents reactive oxygen species generation and retinal endothelial cell damage at high glucose levels[J]. Experimental Eye Research,2010, 90 : 89 - 96.
  • 2Sheikpranbabu S. Pigment epithe|ium - derived factor inhibits ad- vanced glycation end - products - induced cytotoxicity in retinal peri- eytes[ J]. Diabetes Metab,2011,3:6.
  • 3Cai J,Jiang WG,Grant MB,et al. Pigment epithelium - derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1 [ J ]. J Biol Cbem, 2006,281 : 3604 - 3613.
  • 4Cai J, Wu L, Qi X, et al. PEDF regulates vascular permeability by a fl- secretase - mediated pathway[J]. PLoS ONE, 2011,6(6): e21164.
  • 5Gehlbach P,Demetridaes AM,Yamamoto S,et al. Periocular injection of an adenoviral vector encoding pigment epithelium - derived factor inhibits choroidal neovascularization [ J. Nature Publishing Group, 2003,10:637-646.
  • 6Park K, Jin J, Hu Y, et al. Overexpression of pigment epithelium - de- rived factor inhibits retinal inflammation and neovascularizatlon [ J ]. Am J Pathology,2011,178 ( 2 ) : 688 - 698.
  • 7Yamashi S, Nakamura K, Matsui T, et al. Pigment epithelium - de- rived factor inhibits advanced glycation end product - induced retinal vascular hyperpermeability by blocking reactive oxygen species - me- diated vascular endothelial growth factor expression[J]. J Biol Chem, 2006,281 ( 29 ) : 20213 - 20220.
  • 8Yamashi S, Matsui T, Nakamura K, et al. Pigment epithelium - de- rived factor suppresses expression of receptor for advanced glyeation end product in the eye of diabetic rats J. Ophthalmic Res,2007,39: 92 -97.
  • 9Zhang SX, Wang JJ, Gao G. Pigment epithelium - derived factor (PEDF) is a endogenous antiinflammatory factor [ J]. FASEB J, 2006,20 : 323 - 325.
  • 10Wang JJ,Zhang SX,Lu K,et al. Decreased expression of pigment epi- thelium - derived factor is involved in the pathogenesis of diabetic ne- phropathy[ J. Diabetes ,2005,54 : 243 -250.

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部